Proliferation and apoptosis in newly diagnosed and relapsed childhood acute lymphoblastic leukemia

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4327-4331

  Volm, M ^a   Zintl, F ^b   Sauerbrey, A ^b   Koomagi R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Dept 0511 German Cancer Research Center ^*

Author keywords

Apoptosis; Bcl 2; Caspase 3; Cyclin A; Fas; Fas ligand; Immunocytochemistry; Newly diagnosed ALL; Proliferation; Relapsed ALL

Indexed keywords

CASPASE 3; CYCLIN A; FAS ANTIGEN; PROTEIN BCL 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CELL PROLIFERATION; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 0032796452     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Sauerbrey A, Zintl F and Volm M: P-glycoprotein and glutathione S-transferase in childhood acute lymphoblastic leukemia. Br J Cancer 70: 1144-1149, 1994.
2. Volm M, Zintl F, Edler L and Sauerbrey A: Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia. Med Pediatr Oncol 28: 117-126, 1997.
3. Volm M and Mattern J: Resistance mechanisms and their regulation in lung cancer. Crit Rev Oncogenesis 7: 227-244, 1996.
4. Desoize B: Anticancer drug resistance and inhibition of apoptosis. Anticancer Res 14: 2291-2294, 1994.
5. Amadori S, Petti MC, De Franscesco A, Chierichini A, Mastrovincenzo C, Testa MG and Mandelli F: Lack of prognostic significance of the pretreatment labeling and mitotic indices of marrow blasts in acute nonlymphocytic leukemia (ANLL). Cancer 41: 1154-1160, 1978.
6. Sewell RL, Lister TA, Johnson SAN and Crowther J: Lack of prognostic value of the thymidine-labelling index in adult leukemia. Br J Cancer 44: 55-62, 1981.
7. Riccardi A, Giordano M, Danova M, Girino M, Brugnatelli S, Ucci G and Mazzini G. Cell kinetics with in vivo bromodeoxyuridine and flow-cytometry: clinical significance in acute non-lymphoblastic leukaemia. Eur J Cancer 27: 882-887, 1992.
8. Tsurusawa M, Ito M, Zha Z, Kawai S, Takasaki Y and Fujimoto T: Cell cycle-associated expressions of proliferating cell nuclear antigen and Ki-67 reactive antigen of bone marrow blast cells in childhood acute leukemia. Leukemia 7: 669-674, 1992.
9. Volm M, Hecker S, Sauerbrey A and Mattern J: Predictive value of statin, a G0-associated cell cycle protein, in childhood acute lymphoblastic leukemia. Int J Cancer (Pred Oncol) 64: 166-170, 1995.
10. Bhalla K, Ibrado AM, Toukina E, Tang C, Mahoney ME, and Huang Y: Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia. Leukemia 7: 563-568, 1993.
11. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR and Darzynkiewicz Z: Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 7: 659-670, 1993.
12. Carson AD and Ribeiro JM: Apoptosis and diseases. The Lancet 341: 1251-1253, 1993.
13. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
14. Fisher DE: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994.
15. Nagata S and Golstein P: The Fas death factor. Science 267: 1451-1455, 1995.
16. Xerri L, Devilard E, Hassoun J, Mawas C and Birg F: Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. J Clin Pathol: Mol Pathol 50: 87-91, 1997.
17. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M and Lazebnik YA: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43, 1995.
18. Fernandez-Alnemri T, Litwack G and Alnemri ES. CPP32, a novel human apoptotic protein with homology to caenorhabditis elegans cell death Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269: 30761-30764, 1994.
19. Reed J C: Bcl-2 and the regulation of programmed cell death. J cell Biol 124: 1-6, 1994.
20. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR and Sultan C: French-American-British (FAB) cooperative group. Proposal for the classification of the acute leukaemias. Br J Haematol 33: 451-458, 1976.
21. Zintl F, Malke H, Reimann M, Domula M, Dörffel W, Eggers G, Exadaktylos P, Hilgenfeld E, Kotte W, Krause I, Kunert W, Mittler U, Möbius D, Reddemann H, Weinmann G and Weissbach G: Results with randomized BFM adopted studies for ALL therapy in childhood in East German countries. Acute Leukemias IV: Prognostic factors (T. Büchner G, Schellong W, Hiddemann J, Urbanitz J and Ritter J, eds.), pp 179-186, Springer Berlin, 1993.
22. Volm M, Sauerbrey A and Zintl F: Prognostic significance of protein kinase C in newly diagnosed childhood acute lymphoblastic leukemia. Int J Oncol 4: 363-368, 1994.
23. Volm M, Sauerbrey A, Stammler G and Zintl F: Detection of Fos, Jun and Ras in newly diagnosed childhood acute lymphohlastic leukemia by immunocytochemistry and PCR. Int J Oncol 4: 1251-1256, 1994.
24. Krehan A, Lorenz P, Plana-Coll M and Pyerin W: Interaction sites between catalytic and regulatory subunits in human protein kinase CK2 holoenzymes as indicated by chemical cross-linking and immunological investigations. Biochemistry 35: 4966-4975, 1996.
25. Hall PA and Levison DA: Review: Assessment of cell proliferation in histological material. J Clin Path 43: 184-192, 1990.
26. Hall PA and Woods AL: Immunohistochemical markers of cellular proliferation: achievements, problems and prospects. Cell Tiss Kin 23: 505-522, 1990.
27. Cordon- Cardo C: Mutation of cell cycle regulators. Biological and clinical implication for human neoplasia (review). Am J Pathol 147: 545-560, 1995.
28. Paterlin, P, Flejou JF, De Mitri MS, Pisi E, Franco D and Brechot C: Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with low cytometric parameters. J Hepatol 23: 47-52, 1995.
29. Volm M, Koomägi R, Mattern J and Stammler G: Cyclin A is associated with an unfavourable outcome in patients with non-small cell lung carcinomas. Br J Cancer 75: 1774-1778, 1997.
30. Hickman JA: Apoptosis and chemotherapy resistance. Eur J Cancer 6: 921-926, 1996.
31. Cai Z, Stancou R, Körner M and Chouaib S: Impairment of Fas antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells. Int J Cancer 4: 535-546, 1997.
32. Villunger A, Egle A, Kos M Hartmann BL, Geley S, Kofler R and Greil R: Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells. Cancer Res 57: 3331-3334, 1997.
33. Friesen C, Fulda S and Dehatin KM: Deficient activation of the CD95 (Apo-1/Fas) system in drug-resistant cells. Leukemia 11: 1833-1841, 1997.
34. Friesen C, Herr I, Kramer PH and Dehatin KM: Involvement of the CD95 (Apo-1/Fas) receptor/ligand system in leukemic cells. Nature Med 2: 574-577, 1996.
35. Min YH, Lee S, Lee JW, Chong SY, Hahn J and Ko YW: Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapy. Br J Haematol 93: 928-930, 1996.
36. Arai T and Kino I: Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas. J Path 176: 37-44, 1995.
37. Saegusa M, Takano Y and Okayasu I: Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. Jpn J Cancer Res Clin Oncol 121: 357-363, 1995.